3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
79
Neoplasms
9
Carcinoma, Intraductal, Noninfiltrating
5
Breast Neoplasms, Male
4
Neoplasm Metastasis
3
Breast Carcinoma In Situ
3
Arthralgia
3
Triple Negative Breast Neoplasms
2
Sexual Dysfunction, Physiological
1
Seizures
1
Recurrence
1
Pain
1
Osteoporosis
1
Obesity
1
Multiple Endocrine Neoplasia Type 1
1
Lethal Congenital Contracture Syndrome 2
1
Joint Diseases
1
Invasive Breast Cancer
1
Hypogonadism
1
Granulosa Cell Ovarian Cancer
1
Fractures, Bone
1
Erectile Dysfunction
1
Epilepsy
1
Carcinoma, Non-Small-Cell Lung
1
Breast Cancer Metastatic
1
Advanced Metastatic Breast Cancer
1
Advanced Breast Carcinoma
1
Interventions
Doxorubicin
33
Ifosfamide
23
Gemcitabine
19
pazopanib
18
Cyclophosphamide
16
Radiotherapy
15
pembrolizumab
13
Filgrastim
12
Docetaxel
12
Bevacizumab
10
Vincristine
9
Sirolimus
9
Irinotecan
9
Etoposide
9
olaratumab
7
eribulin
7
Sorafenib
7
Radiation
7
temsirolimus
6
Temozolomide
6
Mesna
6
Magnetic Resonance Spectroscopy
6
Cisplatin
6
tazemetostat
5
cixutumumab
5
Trabectedin
5
Radiosurgery
5
Nivolumab
5
Ipilimumab
5
Granulocyte Colony-Stimulating Factor
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma
×
Anastrozole
×
Clear all
No trials found.